We previously reported a splicing defect associated with the deletion of CD22 Exon 12 (CD22E12) in leukemia cells from patients with CD19+ B-precursor acute lymphoblastic leukemia (B-ALL) [7]. This evidence concerns the gene CD22 and leukemia.